← Eichor
Study identifier: NCT06124482 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Performance and Safety Evaluation of the FHK®-CK Knee Prosthesis

Condition: Total Knee Arthroplasty  ·  Sponsor: FH ORTHO

PhaseNA
Planned participants92
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The life expectancy worldwide is increasing and leading to an increase of knee arthroplasty. Also, as millions of people around the world are currently living with a Total Knee Arthroplasty (TKA), the need for revision surgery represents a large public health burden. In this context, FH ORTHO company develops FHK®-CK (prosthesis + ancillary equipment) which is a knee prosthesis for complex first intention and revision knee arthroplasty. This new medical device complements the FHK® standard first-line range (CE marked). The FHK®-CK ancillary equipment were designed by expert knee surgeons and is simple, reliable and reproducible. It allows for maximum versatility while remaining compact. By completing the FHK® range of first intention prostheses, the FHK®-CK allows the surgeon to be on the same level as the competitors by having a first intention and semi-constrained prosthesis. This prosthetic arsenal allows the surgeon to opt for the best solution for his patient so that he can regain mobility and a satisfactory quality of life. Also, in case of failure of the FHK® first-line prosthesis, it will provide the surgeon and the patient with a simple alternative to prosthesis replacement. As it has been developed in line with the first intention, inter-compatibility between the two systems is possible, which simplifies the surgical procedure and reduces the risks for the patient.

This description comes directly from the study's public registry record.

Talk to the study team

Carole CARRÉ  ·  06 40 47 16 71  ·  c.carre@fhortho.com

Delphine KORNER  ·  07 87 86 29 14  ·  d.korner@fhortho.com

Always discuss trial participation with your own doctor first.

Locations (7)

Hôpital Privé La ChâtaigneraieBeaumont, FranceTerminated
CHRU de la Cavale BlancheBrest, FranceRecruiting
Hôpital Beaujon AP-HPClichy, FranceRecruiting
Hôpital Raymond Poincaré AP-HPGarches, FranceRecruiting
CH d'HaguenauHaguenau, FranceRecruiting
Centre Hospitalier Régional Universitaire de NancyNancy, FranceRecruiting
Groupe Hospitalier Pitié Salpêtrière AP-HPParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06124482